Galapagos(GLPGF)
2800 MECHELEN, BelgiumBiotechnology
Focus: Galapagos is a publicly-traded biotech company headquartered in Belgium specializing in drug and antibody therapy discovery across immunology, rare diseases, respiratory, oncology, and nephrology. The company operates as a mid-cap biotech with a diversified pipeline but currently no approved marketed products.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
6+6 this month
Growing — net +6 jobs in 30d
7 jobs added vs 1 removed. Steady team buildout.
Should You Work at Galapagos?
AI assessmentGalapagos offers meaningful pipeline upside and rare disease focus for early-to-mid career scientists, but pre-commercialization stage carries higher execution risk than established biotech peers.
Why Work Here
- Filgotinib has achieved Phase 4 status in Rheumatoid Arthritis and Phase 3 in Psoriatic Arthritis, representing near-term regulatory catalysts with commercial potential
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
JAK inhibitor treatment
Colitis, Ulcerative7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis
Rheumatoid ArthritisHelp build intelligence for Galapagos
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.